Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Immunohistochemistry × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Rectal Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Colonic Neoplasms 5 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Follicular 4 Immunoblastic Lymphadenopathy 4 Colorectal Neoplasms 4 Breast Neoplasms, Male 4 Sezary Syndrome 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Mantle-Cell 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡